Abstract: A plant material comprises a genomic nucleotide sequence encoding a SUSIBA2 or SUSIBA2-like transcription factor under transcriptional control of a promoter active in the plant material. The genomic nucleotide sequence encoding the SUSIBA2 or SUSIBA2-like transcription factor lacks at least a portion of an activation region of a SUSIBA1 or SUSIBA1-like promote represent in an intron of a wild-type version of the genomic nucleotide sequence encoding the SUSIBA2 or SUSIBA2-like transcription factor. The plant material has a controlled production of carbohydrates, in particular starch or starch and fructan. In particular, the plant material can be designed to produce carbohydrates at enhanced levels.

Abstract: The present invention refers to a non-antibiotic therapeutic strategy for inhibiting oro-gastro-intestinal infections and pathogens in general and particularly Heliobacter pylori adherence and colonization in the gastrointestinal channel and preventing or relieving associated oro-gastro-intestinal disease. The invention relates to methods and products based on an active cereal product or ferric quinate. The invention is also applicable to other oro-gastro-intestinal pathogens in both humans and animals.